Blog Posts
Explore timely perspectives from WCG’s clinical trial operations and scientific leaders.
WCG Clinical | Insights
Do all subjects need to be reconsented with the revised consent form?
Blog Posts
WCG Clinical | Insights
Can a protocol get IRB approval during the 30-day IND waiting period?
Blog Posts
WCG Clinical | Insights
Does my customer survey project require IRB review?
Blog Posts
WCG Clinical | Insights
WCG IRB’s Single-Patient Expanded Access Experience Before and During the COVID-19 Pandemic
Blog Posts
WCG Clinical | Insights
Protecting Patients, Protecting Your Study: The Benefits Of A Well-Run Data Monitoring Committee
Blog Posts
WCG Clinical | Insights
Using an IRB’s Site Relationships to Relieve “Site Crunch” and Reduce Trial Pressures
Blog Posts
WCG Clinical | Insights
Is informed consent needed for post-market patient registry?
Blog Posts
WCG Clinical | Insights
Does the IRB need to approve doctor-to-doctor letters?
Blog Posts
WCG Clinical | Insights
What are the IRB review requirements for human factors/usability testing?
Blog Posts
WCG Clinical | Insights